| Report ID |
41428 |
| Drug Identification Number |
02049481 |
| Brand name |
NOVAHISTEX DH |
| Common or Proper name |
Novahistex DH 100ml |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
PHENYLEPHRINE HYDROCHLORIDE
HYDROCODONE BITARTRATE |
| Strength(s) |
20MG
5MG |
| Dosage form(s) |
SYRUP |
| Route of administration |
ORAL |
| Packaging size |
100ml |
| ATC code |
R05DA |
| ATC description |
COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for shortage |
Demand increase for the drug. |
| Anticipated start date |
2018-03-21 |
| Actual start date |
|
| Estimated end date |
2018-05-16 |
| Actual end date |
2018-05-07 |
| Shortage status |
Resolved |
| Updated date |
2018-05-08 |
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
